2MASLD [1] 2015201950% [1] 2030 70.56.1 [2] -1GLP-1RA [1-4] GLP-1RAGLP-1GLP-1R [2] 2024 [2] cAMP -arrestin [1] 1 GLP-1RA cAMP -arrestin cAMP GLP-1RA [1-3] 2 GLP-1RA [1-3] 1GLP-1RA GLP-1RAGLP-1GLP-1/GIPGLP-1/GCGGLP-1GIPGCG [5,6] GIPGIPRGLP-1 [ 2 ] [7] GLP-1 -arrestin GIP -arrestin GIP GCG GCG GLP-1 GLP-1 GCG [2] GCG GCGR [6] [8] [1] [6,8] 2 GLP-1RA [9] GLP-1RA EcnoglutideOrforglipronGSBR-1290SAL0112DD202-114 [9] G/cAMP-arrestin GLP-1RA [9] GLP-1RA 2012 G GPCR [ 4 10] GLP-1RA GLP-1GcAMP-arrestin [11] -GLP-1 [ 11 ] 3 GLP-1RA GLP-1RA GLP-1 Kd 10 [11] SLIMMER [1] cAMP cAMP-arrestin [11] SLIMMER 48 [1] GLP-1RA - - - - 2030 21 SCI 120 1.Ji L, Gao L, et al
Key observations about Ozempic, other semaglutide medications such as Wegovy and sexual function: The effects on libido may vary significantly between individuals [2] Changes in sexual function aren't officially listed on Ozempic's label Most side effects are primarily gastrointestinal-related [3] Weight loss achieved through GLP-1 agonists (such as Wegovy) may lead to hormonal changes affecting sexual function [4] GLP-1 agonists like Ozempic work by modulating brain reward systems, which overlap with pathways involved in sexual arousal and satisfaction
Losing too much muscle while taking a GLP-1 medication can result in decreased strength, slower metabolism, increased risk of falls, and a higher likelihood of regaining weight once you stop taking the medication
Our team has supported 30,000+ patients through medically supervised weight management
